Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients
Open Access
- 29 September 2011
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 18 (5) , 731-738
- https://doi.org/10.1016/j.bbmt.2011.09.007
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Adenoviruses in Immunocompromised HostsClinical Microbiology Reviews, 2008
- Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantationJournal of Clinical Virology, 2007
- Adenoviral Infections after Transplantation of Positive Selected Stem Cells from Haploidentical Donors in Children: An UpdateKlinische Padiatrie, 2005
- Treatment of adenovirus infections in the immunocompromised hostEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- ADENOVIRUS INFECTION IN PEDIATRIC SMALL BOWEL TRANSPLANTATION RECIPIENTSTransplantation, 2003
- The impact of adenovirus infection on the immunocompromised hostReviews in Medical Virology, 2003
- Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2003
- Adenovirus Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 1999
- Adenovirus infection after pediatric bone marrow transplantationBone Marrow Transplantation, 1999
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985